22 Examining Post-donation Outcomes in Hispanic/Latinx Living Kidney Donors in the United States: A Systematic Review

2021 ◽  
Vol 77 (4) ◽  
pp. 573
Keyword(s):  
United States ◽  
Systematic Review ◽  
The United States ◽  
Kidney Donors ◽  
Living Kidney Donors

scholarly journals Mortality in Living Kidney Donors With ESRD: A Propensity Score Analysis Using the United States Renal Data System

2018 ◽  
Vol 3 (5) ◽  
pp. 1050-1056 ◽  
Author(s):  
Amarpali Brar ◽  
Dimitre G. Stefanov ◽  
Rahul M. Jindal ◽  
Moro O. Salifu ◽  
Madhu Joshi ◽  
...  
Keyword(s):  
United States ◽  
Propensity Score ◽  
Propensity Score Analysis ◽  
The United States ◽  
Data System ◽  
Kidney Donors ◽  
Living Kidney Donors ◽  
Score Analysis

scholarly journals Variation of ApoL1 Testing Practices for Living Kidney Donors

2019 ◽  
Vol 30 (1) ◽  
pp. 22-28 ◽  
Author(s):  
Tristan McIntosh ◽  
Sumit Mohan ◽  
Deirdre Sawinski ◽  
Ana Iltis ◽  
James M. DuBois
Keyword(s):  
United States ◽  
African Ancestry ◽  
The United States ◽  
West African ◽  
Kidney Donors ◽  
Living Kidney Donors ◽  
Risk Variants ◽  
Increased Risk ◽  
Testing Practices ◽  
West African Ancestry

Introduction: Tests exist for ApoL1 genetic variants to determine whether a potential donor’s kidneys are at increased risk of kidney failure. Variants of the ApoL1 gene associated with increased risk are primarily found in people with West African ancestry. Given uncertainty about clinical implications of ApoL1 test results for living kidney donors and recipients and the lack of uniform guidelines for ApoL1 testing, transplant centers across the United States vary in ApoL1 testing practices. Research Questions: (1) What approach do transplant centers take to determine whether prospective donors are of West African ancestry? (2)How do transplant centers engage potential donors during the ApoL1 testing process? (3) What do transplant centers identify as concerns and barriers to ApoL1 testing? and (4) What actions do transplant centers take when a potential donor has 2 ApoL1 risk variants? Design: We explored the current practices of transplant centers by surveying nephrologists and transplant surgeons at transplant centers evaluating the majority of black living donors in the United States. Results: About half of these transplant centers offered ApoL1 testing. Of those who offered ApoL1 testing, only half involved the donor in decision-making about donation when the donor has 2 risk variants. Discussion: Unaddressed differences in the priorities of transplant centers and black living donors may stigmatize black donors and undermine trust in the health-care and organ donation systems. Variation in transplant center testing practices points to the critical need for further research and community engagement to inform the development of guidelines for ApoL1 testing.

scholarly journals Comorbidity Burden and Perioperative Complications for Living Kidney Donors in the United States

2013 ◽  
Vol 8 (10) ◽  
pp. 1773-1782 ◽  
Author(s):  
Jesse D. Schold ◽  
David A. Goldfarb ◽  
Laura D. Buccini ◽  
James R. Rodrigue ◽  
Didier A. Mandelbrot ◽  
...  
Keyword(s):  
United States ◽  
Perioperative Complications ◽  
The United States ◽  
Kidney Donors ◽  
Living Kidney Donors ◽  
Comorbidity Burden

Medical evaluation of living kidney donors with nephrolithiasis: a survey of practices in the United States

2019 ◽  
Vol 24 (3) ◽  
pp. 259-267
Author(s):  
V. S. Tatapudi ◽  
F. Modersitzki ◽  
S. Marineci ◽  
M. A. Josephson ◽  
D. S. Goldfarb
Keyword(s):  
United States ◽  
The United States ◽  
Kidney Donors ◽  
Living Kidney Donors ◽  
Medical Evaluation

scholarly journals Critical Factors Associated With Missing Follow-Up Data for Living Kidney Donors in the United States

2015 ◽  
Vol 15 (9) ◽  
pp. 2394-2403 ◽  
Author(s):  
J. D. Schold ◽  
L. D. Buccini ◽  
J. R. Rodrigue ◽  
D. Mandelbrot ◽  
D. A. Goldfarb ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Critical Factors ◽  
Kidney Donors ◽  
Living Kidney Donors ◽  
Factors Associated

Return on investment for financial assistance for living kidney donors in the United States

2018 ◽  
Vol 32 (7) ◽  
pp. e13277 ◽  
Author(s):  
Amit K. Mathur ◽  
Jiawei Xing ◽  
David M. Dickinson ◽  
Patricia H. Warren ◽  
Kimberly A. Gifford ◽  
...  
Keyword(s):  
United States ◽  
Return On Investment ◽  
The United States ◽  
Financial Assistance ◽  
Kidney Donors ◽  
Living Kidney Donors

Leveraging Technology in Detection of Alzheimer’s Disease: A Systematic Review (Preprint)

2019 ◽  
Author(s):  
Clemens Kruse ◽  
Britney Larson ◽  
Reagan Wilkinson ◽  
Roger Samson ◽  
Taylor Castillo
Keyword(s):  
Magnetic Resonance Imaging ◽  
United States ◽  
Systematic Review ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
The United States ◽  
Diagnostic Process ◽  
Resonance Imaging ◽  
Common Cause ◽  
Key Terms

BACKGROUND Incidence of AD continues to increase, making it the most common cause of dementia and the sixth-leading cause of death in the United States. 2018 numbers are expected to double by 2030. OBJECTIVE We examined the benefits of utilizing technology to identify and detect Alzheimer’s disease in the diagnostic process. METHODS We searched PubMed and CINAHL using key terms and filters to identify 30 articles for review. We analyzed these articles and reported them in accordance with the PRISMA guidelines. RESULTS We identified 11 technologies used in the detection of Alzheimer’s disease: 66% of which used some form of MIR. Functional, structural, and 7T magnetic resonance imaging were all used with structural being the most prevalent. CONCLUSIONS MRI is the best form of current technology being used in the detection of Alzheimer’s disease. MRI is a noninvasive approach that provides highly accurate results in the diagnostic process of Alzheimer’s disease.

A Systematic Review on Barriers to Palliative Care in Oncology

2021 ◽  
pp. 104990912098328
Author(s):  
Jyotsana Parajuli ◽  
Judith E. Hupcey
Keyword(s):  
United States ◽  
Systematic Review ◽  
Palliative Care ◽  
Full Text ◽  
Literature Search ◽  
Intervention Development ◽  
The United States ◽  
Care Utilization ◽  
Review Of Literature ◽  
Meta Analyses

The number of people with cancer and the need for palliative care among this population is increasing in the United States. Despite this growing need, several barriers exist to the utilization of palliative care in oncology. The purpose of this study was to synthesize the evidence on the barriers to palliative care utilization in an oncology population. A systematic review of literature was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, CINAHL, and Psych Info databases were used for the literature search. Articles were included if they: 1) focused on cancer, (2) examined and discussed barriers to palliative care, and c) were peer reviewed, published in English, and had an accessible full text. A total of 29 studies (8 quantitative, 18 qualitative, and 3 mixed-methods) were identified and synthesized for this review. The sample size of the included studies ranged from 10 participants to 313 participants. The barriers to palliative care were categorized into barriers related to the patient and family, b) barriers related to providers, and c) barriers related to the healthcare system or policy. The factors identified in this review provide guidance for intervention development to mitigate the existing barriers and facilitate the use palliative care in individuals with cancer.

Sign in / Sign up

Export Citation Format

Share Document